Folate receptor α expression and significance in endometrioid endometrium carcinoma and endometrial hyperplasia.
about
Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients.New therapies for advanced, recurrent, and metastatic endometrial cancers.In vitro and in vivo activity of IMGN853, an Antibody-Drug Conjugate targeting Folate Receptor Alpha linked to DM4, in biologically aggressive endometrial cancers.Hypocrellin B-loaded, folate-conjugated polymeric micelle for intraperitoneal targeting of ovarian cancer in vitro and in vivo.Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response.
P2860
Folate receptor α expression and significance in endometrioid endometrium carcinoma and endometrial hyperplasia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Folate receptor α expression a ...... a and endometrial hyperplasia.
@ast
Folate receptor α expression a ...... a and endometrial hyperplasia.
@en
type
label
Folate receptor α expression a ...... a and endometrial hyperplasia.
@ast
Folate receptor α expression a ...... a and endometrial hyperplasia.
@en
prefLabel
Folate receptor α expression a ...... a and endometrial hyperplasia.
@ast
Folate receptor α expression a ...... a and endometrial hyperplasia.
@en
P2093
P2860
P1476
Folate receptor α expression a ...... a and endometrial hyperplasia.
@en
P2093
Abdullah Aydin
Ayse Bahar Ceyran
Duygu Kösemetin
Ebru Zemheri
Ibrahim Akalin
Ibrahim Sehitoglu
Serkan Senol
Seyma Ozkanli
P2860
P304
P577
2015-05-01T00:00:00Z